Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cuadrado, M.J.
Right arrow Articles by Hughes, G.R.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuadrado, M.J.
Right arrow Articles by Hughes, G.R.V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2001; 94: 114-115
© 2001 Association of Physicians

Correspondence

Migraine in Hughes syndrome—heparin as a therapeutic trial?

M.J. Cuadrado, M.A. Khamashta, D. D'Cruz and G.R.V. Hughes

Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London

Sir,

One of the most prominent features of the procoagulant antiphospholipid (Hughes) syndrome (APS) is headache.1 These vary from classical intermittent migraine to almost continuous incapacitating headache. Over and above the considerable fear of stroke in these patients, the headaches are, themselves, often . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?